MicroRNA expression profiles in patients with acute Crimean Congo hemorrhagic fever reveal possible adjustments to cellular pathways

Journal of Medical Virology

Volumn 89, Issue 3, 2017, Pages 417-422

  Demir, Zekiye Cemre ^a   Bastug, Aliye ^b   Bodur, Hurrem ^b   Ergunay, Koray ^c   Ozkul, Aykut ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Crimean Congo Hemorrhagic Fever; miRNA; pathogenesis

Indexed keywords

CYTOKINE; MICRORNA; MICRORNA 146A; MICRORNA 154; MICRORNA 299; MICRORNA 31; MICRORNA 32; MICRORNA 335; MICRORNA 410; MICRORNA 411; MICRORNA 451; MICRORNA 486 5P; MICRORNA 541; MICRORNA 549; MICRORNA 575; MICRORNA 608; MICRORNA 655; MICRORNA 889; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION; VIRUS LOAD; YOUNG ADULT; ADOLESCENT; GENE EXPRESSION PROFILING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MONONUCLEAR CELL; PATHOLOGY;

ADOLESCENT; ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; HEMORRHAGIC FEVER, CRIMEAN; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84995969109     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24667     Document Type: Article

References (34)

1. Akinci E, Bodur H, Leblebicioglu H. 2013. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis 13:429–437.
2. Baril M, Es-Saad S, Chatel-Chaix L, Fink K, Pham T, Raymond V-A, Audette K, Guenier A-S, Duchaine J, Servant M, Bilodeau M, Cohen E, Grandvaux N, Lamarre D. 2013. Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses. PLoS Pathog 9:e1003416.
3. Bartel DP. 2009. MicroRNA target recognition and regulatory functions. Cell 136:215–233.
4. Bergeron E, Vincent MJ, Nichol ST. 2007. Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity. J Virol 81:13271–13276.
5. Blakqori G, Delhaye S, Habjan M, Blair CD, Sanchez-Vargas I, Olson KE, Attarzadeh-Yazdi G, Fragkoudis R, Kohl A, Kalinke U, Weiss S, Michiels T, Staeheli P, Weber F. 2007. La crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol 81:4991–4999.
6. Cai X, Hagedorn CH, Cullen BR. 2004. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10:1957–1966.
7. Chinnappan M, Singh AK, Kakumani PK, Kumar G, Rooge SB, Kumari A, Varshney A, Rastogi A, Singh AK, Sarin SK, Malhotra P, Mukherjee SK, Bhatnagar RK. 2014. Key elements of the RNAi pathway are regulated by hepatitis B virus replication and HBx acts as a viral suppressor of RNA silencing. Biochem J 462:347–358.
8. Ergonul O. 2012. Crimean-Congo hemorrhagic fever virus: New outbreaks, new discoveries. Curr Opin Virol 2:215–220.
9. Ergunay K, Kocak Tufan Z, Bulut C, Kinikli S, Demiroz AP, Ozkul A. 2014. Antibody responses and viral load in patients with Crimean-Congo hemorrhagic fever: A comprehensive analysis during the early stages of the infection. Diagn Microbiol Infect Dis 79:31–36.
10. Gentner B, Naldini L. 2012. Exploiting microRNA regulation for genetic engineering. Tissue Antigens 80:393–403.
11. Gupta A, Swaminathan G, Martin-Garcia J, Navas-Martin S. 2012. MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: New insights in pathogenesis and therapy. Viruses 4:2485–2513.
12. Hennessya E, Clynesa M, Jeppesenb PB, O'Driscollc L. 2010. Identification of microRNAs with a role in glucose stimulated insulin secretion by expression profiling of MIN6 cells. Biochem Biophys Res Commun 396:457–462.
13. Honig JE, Osborne JC, Nichol ST. 2004. Crimean-Congo hemorrhagic fever virus genome L RNA segment and encoded protein. Virology 321:29–35.
14. Kakumani PK, Ponia S, Rajgokul KS, Sood V, Chinnappan M, Banerjea AC. 2013. Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor. J Virol 87:8870–8883.
15. Kyriakidis I, Papa A. 2013. Serum TNF-α, sTNFR1, IL-6, IL-8 and IL-10 levels in hemorrhagic fever with renal syndrome. Vir Res 175:91–94.
16. Li G, Luna C, Wu J, Qiu J, Epstein DL, Gonzalez P. 2011. Anti-inflammatory role of miR-493 in senescent trabecular meshwork cells. Invest Ophthalmol Vis Sci 52:1428–1428.
17. H Li, Jiang J-d, Peng Z-g. 2016. MicroRNA-mediated interactions between host and hepatitis C virus. World J Gastroenterol 22:1487–1496.
18. Maniataki E, Mourelatos Z. 2005. A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes and Dev 19:2979–2990.
19. Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Cristensen RN, Schmidt WN, McCaffrey AP. 2010. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest 90:1727–1736.
20. Morita K, Taketomi A, Shirabe K, Umeda K, Kayashima H, Ninomiya M, Uchiyama H, Soejima Y, Maehara Y. 2011. Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int 31:474–484.
21. Ninomiya M, Kondo Y, Kimura O, Funayama R, Nagashima T, Kogure T, Morosawa T, Tanaka Y, Nakayama K, Shimosegawa T. 2016. The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen. J Viral Hepat 23:330–339.
22. Olmstead AD, Knecht W, Lazarov I, Dixit SB. 2012. Human subtilase SKI-1/S1P is a master regulator of the HCV lifecycle and a potential host cell target for developing indirect-acting antiviral agents. PLoS Pathog 8:e1002468.
23. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. 2006. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 36:272–276.
24. Papa A, Pappa S, Panayotova E, Papadopoulou E, Christova I. 2016. Molecular epidemiology of Crimean–Congo hemorrhagic fever in Bulgaria—An update. J Med Virol 88:769–773.
25. Pasquinelli AE. 2012. MicroRNAs and their targets: Recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13:271–282.
26. Pepini T, Gorbunova EE, Gavrilovskaya IN, Mackow JE, Mackow ER. 2010. Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability. J Virol 84:11929–11936.
27. Plyusnin A, Beaty BJ, Elliott RM, Goldbach R, Kormelink R, Lundkvist Å, Schmaljohn CS, Tesh RB. 2012. In: Lefkowitz EJ, Adams MJ, Carstens EB, editors. Virus taxonomy: Classification and nomenclature of viruses. San Diego: Elsevier, pp 725–741.
28. Qi Y, Li Y, Zhang LIN, Huang J. 2013. MicroRNA expression profiling and bioinformatic analysis of dengue virus - infected peripheral blood mononuclear cells. Mol Med Rep 7:791–798.
29. Rosenberger CM, Podyminogin RL, Navarro G, Zhao G-w. 2012. MiR-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol 189:5965–5975.
30. Whitehouse CA. 2004. Crimean-Congo hemorrhagic fever. Antiviral Res 64:145–160.
31. Witwer KW, Watson AK, Blankson JN, Clements JE. 2012. Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 12:9–5.
32. Witwer KW. 2014. HIV-1 Tat- and Vpr-responsive microRNAs of neuronal cells. J Biol Chem 289:3104.
33. Wolfel R, Paweska JT, Petersen N, Grobbelaar AA, Leman PA, Hewson R, Georges-Courbot MC, Papa A, Gunther S, Drosten C. 2007. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. EID 13:1097–1100.
34. Wu S, He L, Li Y, Wang T. 2013. MiR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. J Infect 67:329–341.